Citigroup Inc Clene Inc. Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$0.92 - $1.11 $92 - $111	100 New	100 $0
Q2 2022 Aug 10, 2022	SELL	$2.1 - $4.12 $1,362 - $2,673	-649 Reduced 82.57%	137 $0
Q1 2022 May 12, 2022	SELL	$2.42 - $4.42 $11,330 - $20,694	-4,682 Reduced 85.63%	786 $3,000
Q4 2021 Feb 10, 2022	BUY	$3.95 - $7.53 $12,482 - $23,794	3,160 Added 136.92%	5,468 $22,000
Q3 2021 Nov 10, 2021	BUY	$6.83 - $13.58 $15,763 - $31,342	2,308 New	2,308 $16,000

7.44M

48.1K

160K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $21M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.